Dianalitics
Apogee Enterprises, Inc.
APOG · v3 · 2026-10-11
hourglass
Loading…
Preparing the latest DD data, styles and content.
69OpportunityDD: Oct 11, 2026Analyst: 72
paidPrice at analysis date
USD 40.6 (11/10/2026)
domainMkt cap
$848.07M
pie_chartShares
20.90M
candlestick_chart52W
$30.75-$50.88
trending_downShort interest
3.8%
INFOInformation TechnologyFounded 1949
Verdict: Favorable Risk/Reward

APOG is a FATTORIALE value-quality candidate: the latest quarter delivered revenue growth, margin progress, a raised FY2027 outlook, ongoing buybacks and a dividend, while the stock still trades near 7.4x trailing EV/EBITDA and below premium building-products peers. The key debate is whether Kalwall/Groglass and Project Fortify can offset lower underlying volumes and higher debt.

DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 - updated 2026-10-11
72
Apogee Enterprises, Inc. (APOG)
Industrials / Architectural building products - Nasdaq
A self-help industrial small cap with real earnings, buybacks and M&A optionality, tempered by cyclicality, material-cost pressure and acquisition leverage.
FATT - VALUE Q2 beat and raise Buyback + dividend Kalwall/Groglass integration
Fin. strength
13
/20 pts
EBITDA/FCF
12
/15 pts
Debt/leverage
10
/15 pts
Stage/business
12
/15 pts
Catalysts
7
/10 pts
Reg. risk
7
/8 pts
Risk/reward
5
/7 pts
Management
3
/5 pts
Sector/macro
2
/3 pts
Compliance
1
/2 pts
FV base case
Fair value base case
USD 49.5
Range: USD 33.3-USD 33.3
Price at analysis date: USD 40.6 (11/10/2026)
Base upside/downside: +22%

Analyst-normalized EBITDA and scenario multiples, less net debt, divided by 20.893M filed shares outstanding. The $155M base EBITDA is below the report's $172M-$180M FY2027 estimate to allow for the cycle and integration uncertainty; it is not company guidance. Base upside is about 22% from the $40.59 price used. The 14x adjusted EPS cross-check gives $44.80 and a 1.0x EBITDA multiple change moves value by about $7.42/share. Dividend and repurchase cash flows are not added to enterprise value. Not investment advice.

ComponentAssumptionUSD/share
Normalized enterprise value$155M EBITDA x 8.6x = $1,333.0M / 20.893M shares+63.80
Net debt bridge($335.545M debt - $36.529M cash) / 20.893M shares-14.31
FV base case($1,333.0M enterprise value - $299.016M net debt) / 20.893M shares~$49.50
Bull
$64.13
Probability: 30%
$180M normalized EBITDA at 9.0x less $280M net debt; acquisitions prove accretive and operating cash converts to debt reduction.
Base
$49.50
Probability: 45%
$155M normalized EBITDA at 8.6x less $299M reported net debt; a conservative cycle and integration assumption.
Bear
$33.26
Probability: 25%
$145M normalized EBITDA at 7.0x less $320M net debt as weak volumes and integration costs slow deleveraging.
Methodology: Analyst-normalized EBITDA and scenario multiples, less net debt, divided by 20.893M filed shares outstanding. The $155M base EBITDA is below the report's $172M-$180M FY2027 estimate to allow for the cycle and integration uncertainty; it is not company guidance. Base upside is about 22% from the $40.59 price used. The 14x adjusted EPS cross-check gives $44.80 and a 1.0x EBITDA multiple change moves value by about $7.42/share. Dividend and repurchase cash flows are not added to enterprise value. Not investment advice. Not investment advice.
check_circle
Factor screen
Selected in FATTORIALE mode with a VALUE tag: APOG is not a hyper-growth setup, but the combination of Q2 FY2027 beat-and-raise, share-count reduction, dividend yield, low valuation multiples and visible operating cash flow creates a clean factor profile.
📊 Capital Structure | Short Interest | Buyback & Dilution
🟢 Short interest
3.8%
786,652 shares short as of 2026-09-30, 2.75 days to cover. Low-to-moderate skepticism; not a squeeze thesis.
🟢 Share dilution (1Y)
-2.9%
Filed quarter-end shares declined from 21.516M a year earlier to 20.893M at August 2026. Buybacks totaled $16.1M fiscal YTD.
🟢 Buyback
$16.1M YTD
Capital returns totaled $27.3M fiscal YTD including dividends; debt now matters after acquisitions.
Short interest as a share of float
APOG - 3.8%
3.8%

Insider check: public Form 4 screens show Mark Richard Augdahl reported roughly $700K of tax/retention-related disposition activity in early 2026, and Donald Nolan reported smaller disposition activity. These are not enough to override the buyback thesis, but they should be monitored after the Q2 price spike.

$Financial analysis - FY
Q2 FY2027 net sales
$391.1M
Up 9.2% YoY, helped by Kalwall, price and mix
Q2 adj. EBITDA
$49.5M
Up 11.7% YoY; margin rose to 12.7%
FY2027 sales guide
$1.46-$1.50B
Raised from $1.38-$1.43B
Leverage
1.7x
Higher debt after M&A but still manageable
ItemFY2025FY20261H FY2027FY2027EGuidance / read-through
Net sales~$1.36B$1.40B$733.8M$1.46B-$1.50BRaised after Q2 beat and acquisitions
Adjusted EBITDA~$193M$167M$81.7M~$172M-$180MStabilizing after FY2026 margin compression
Adjusted EPS~$4.97$3.47$1.74$3.00-$3.40Raised from $2.70-$3.25
Operating cash flow$125.2M$122.5M$43.3MNot guided1H FY2027 vs $37.3M in 1H FY2026
Capital expenditure$35.6M$27.3M$17.8M$35M-$40MFY2027 capex range is company guidance
Free cash flow+$89.6M+$95.2M+$25.5MNot guided1H FY2027 vs +$25.5M in 1H FY2026
Free cash flow equals operating cash flow less capital expenditure. FY2027E EBITDA is an analyst estimate, not company guidance. The half-year column is not comparable with full fiscal years; compare its cash flow with the corresponding prior half-year below.
Quarterly dynamics - last 5 quarters
MetricQ2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027Q2 FY2027
Revenue ($M)358.2348.6351.4342.7391.1
Gross margin %23.1%N/D22.4%N/D24.6%
Net earnings ($M)23.6N/D~16.711.522.4
Cash EOP ($M)N/DN/D~33N/D~33
Financial position and sustainability
Annual measure ($M)FY2024FY2025FY2026Aug 2026
Net debt at period-end24.8243.6192.8299.0
Operating cash flow204.2125.2122.5See half-year table
Capital expenditure43.235.627.3See half-year table
Free cash flow+161.0+89.6+95.2See half-year table
Comparable first-half cash flow ($M)
Measure1H FY20261H FY2027
Operating cash flow37.343.3
Capital expenditure11.817.8
Free cash flow+25.5+25.5
Annual FCF fell sharply from FY2024 and recovered only modestly in FY2026. First-half FY2027 FCF of $25.463M was essentially unchanged from $25.453M a year earlier. Net debt rose to $299.0M at August 2026 from $192.8M at FY2026 year-end as acquisition spending increased; the 1.7x credit-agreement leverage ratio uses a different covenant definition.
FY2027 guide
Raised
Leverage
1.7x
Volume risk
Medium
account_tree

Business model - specialty architectural products platform

Value depends on mix shift, not just construction volume
Apogee sells architectural metals, services, glass and performance surfaces used in commercial buildings and differentiated specialty applications. The current thesis is not broad construction acceleration; it is that acquisitions, pricing, productivity and higher-value product mix lift margins even while base volume stays uneven.

Architectural Metals ~$265M 1H FY2027 sales, 13.5% EBITDA margin margin anchor Largest segment and a key Fortify beneficiary. Price, productivity and mix are offsetting volume softness. Architectural Services ~$225M 1H FY2027 sales, 5.5% EBITDA margin low margin Project execution and backlog quality matter; lower margins limit valuation unless services profitability improves. Architectural Glass ~$145M 1H FY2027 sales, 13.1% adj. EBITDA margin steady Viracon and specialty glass capabilities provide specification value, with Groglass adding differentiated surfaces. Performance Surfaces ~$100M 1H FY2027 sales, 19.1% adj. EBITDA margin quality mix Highest-margin segment; Kalwall and UW Solutions-type assets are intended to increase this differentiated mix.

gavel

Legal, regulatory and risk analysis

Construction cycle
High
Commercial construction and renovation demand can slow before reported margins roll over. Lower volume was still a negative factor in Q2.
Acquisition leverage
Medium
Debt rose after Kalwall/Groglass activity. The 1.7x leverage ratio is manageable, but it narrows room for buybacks if integration disappoints.
Material costs
Medium
Aluminum and manufacturing costs remain a recurring margin pressure. Pricing needs to keep offsetting input inflation.
Low service margin
Medium
Architectural Services still carries lower EBITDA margins, so project execution errors can dilute group margin quickly.
Q2 beat-and-raise
Positive
The October 2026 result raised FY2027 revenue and adjusted EPS guidance, confirming better first-half execution.
Capital returns
Positive
Buybacks plus dividends create tangible per-share support while the stock trades at a mid-single-digit sales multiple and low EBITDA multiple.
Governance check
Low
The required search did not surface a fresh securities class action, SEC investigation or short-seller report in the last 90 days. Insider dispositions appear manageable rather than thesis-breaking.
Dividend and ex-date
Positive
The next dividend cycle has an October 20, 2026 ex-date and November 4 payable date, reinforcing yield support for value investors.
article

SWOT analysis

Strengths
  • +Q2 FY2027 showed revenue, adjusted EBITDA and adjusted EPS growth.
  • +Raised guidance validates the self-help and acquisition thesis.
  • +Buybacks reduced share count and dividend yield supports value screen.
  • +Architectural Services backlog reached $833M at Q2, above $792.3M at FY2026 year-end.
Weaknesses
  • −Organic volume is still uneven in several segments.
  • −Net debt rose to $299.0M at August 2026 after acquisitions.
  • −Service margins remain structurally lower than product margins.
  • −Annual free cash flow fell from $161.0M in FY2024 to $95.2M in FY2026.
Opportunities
  • →Kalwall/Groglass can improve differentiated product mix.
  • →Project Fortify can keep margin above prior trough levels.
  • →A rerating toward 9x-10x EBITDA would create meaningful upside.
  • →Profitable conversion of the Services backlog could strengthen cash generation.
Threats
  • !A commercial construction downturn can pressure orders and backlog.
  • !Material-cost inflation can absorb pricing gains.
  • !Acquisition integration missteps would make higher leverage harder to defend.
  • !First-half FY2027 FCF was essentially flat year over year despite higher operating cash flow, limiting near-term deleveraging.
article

Summary by assessment area

Quality - improving
  • Q2 adjusted EBITDA rose 11.7% and margin expanded to 12.7%.
  • Higher-value acquisitions can lift group mix if integration is clean.
Valuation - favorable
  • Base FV of $49.50 implies about 22% upside from the Oct. 9 close.
  • APOG trades below premium peers despite a better FY2027 guide.
Risk - cyclical
  • The stock remains exposed to construction volume and material costs.
  • Debt is manageable but less forgiving after the acquisition step-up.
Sources & Disclaimer

Sources: Apogee Q2 FY2027 release and Q2 Form 10-Q for August 2026 debt, cash, shares and first-half cash flow; Q1 FY2027 release for quarterly history; FY2026 Form 10-K and FY2024 Form 10-K for annual FCF and net debt. MarketBeat and Nexqual quote snapshots; StockAnalysis statistics; MarketBeat short-interest data. Market data as of 2026-10-09 close: APOG current price used $40.59, market cap ~$848.17M, 52W range $30.75-$50.88, shares outstanding ~20.90M, short interest 786,652 shares / 3.8% of float / 2.75 days to cover as of 2026-09-30. Price sanity check: $40.59 x 20.893M filed shares ~= $848.07M market cap, consistent with the quoted ~$848.17M. FY2024 contained 53 weeks; FY2025 and FY2026 had 52 weeks. This document is for informational purposes only and does not constitute financial or investment advice.